Published date: 22 August 2017

Last edited date: 22 August 2017

This notice was replaced on 19 December 2017

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Awarded contract (published 19 December 2017)

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Contract summary

Industry

  • Blood coagulants - 33141530

Location of contract

Any region, North East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West, Scotland, Wales, Northern Ireland, Isle of Man, Channel Islands

Value of contract

£302,000,000

Procurement reference

tender_140982/607405

Published date

22 August 2017

Closing date

22 September 2017

Contract start date

1 February 2018

Contract end date

30 June 2020

Contract type

Supply contract

Procedure type

Open procedure

Any interested supplier may submit a tender in response to an opportunity notice.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

Invitation to offer for NHS Framework Agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders. Period of contract: 1st February 2018 to 31st January 2019 with options to extend up to a further 17 months. Total maximum framework agreement period including extensions will be no more than 29 months

More information

Attachments

Links

About the buyer

Contact name

Philip Grieve

Address

2nd Floor, Rutland House
Runcorn
WA7 2ES
England

Email

philip.grieve@nhs.net